Publication
Title
Staging of non-small cell lung cancer : consensus, controversies and challenges
Author
Abstract
Stage is with performance status, the most potent prognostic factor in non-small cell lung cancer. In the past decades, much effort has been directed towards the definition, description. development and implementation of staging guidelines. This has undoubtedly resulted in improvements in therapy and insight in the biology of the disease. The new millennium sees us confronted with an increasing epidemic of lung cancer. Hence, the need for further improvements in staging accuracy and cost effectiveness, in order to use the available therapeutic armament at its best and provide the patient with a treatment that is best adjusted to his or her condition. Current controversies and future challenges in staging will be addressed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
Language
English
Source (journal)
Lung cancer: journal of the International Association for the Study of Lung Cancer / International Association for the Study of Lung Cancer [Aurora, Colo.] - Amsterdam
Publication
Amsterdam : 2001
ISSN
0169-5002
Volume/pages
34:S:2(2001), p. 95-107
ISI
000172970000015
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
[E?say:metaLocaldata.cgzprojectinf]
Publication type
Subject
External links
Web of Science
Record
Identification
Creation 18.11.2014
Last edited 12.10.2017